Upgrade to SI Premium - Free Trial

Lantern Pharma (LTRN)

0.68 +0.02 (3.03%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Form ARS Lantern Pharma Inc. For: Dec 31 October 21, 2026 6:02 AM - SEC Filing Form DEF 14A Lantern Pharma Inc. For: Oct 19 October 19, 2026 4:15 PM - SEC Filing Powering the AI Economy: New to The Street Show #776 Premieres Tonight on Bloomberg Television October 17, 2026 12:37 PM - StreetInsider Form SCHEDULE 13G/A Lantern Pharma Inc. Filed by: Empery Asset Management, LP October 13, 2026 12:52 PM - SEC Filing New to The Street Show 775 Premieres Tonight on Bloomberg Television Across the United States, Latin America, MENA and Southeast Asia, Featuring American Fusion, HPB, T-REX Acquisition Corp. and SyncM October 10, 2026 10:57 AM - StreetInsider Form PRE 14A Lantern Pharma Inc. For: Oct 08 October 8, 2026 4:05 PM - SEC Filing Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 15th, 2026 October 8, 2026 8:00 AM - BizWire Lantern Pharma gets Taiwan approval for next phase of LP-300 trial October 7, 2026 8:31 AM - StreetInsider Lantern Pharma Receives Taiwan Approvals to Open Next Stage of Phase 2 HARMONIC™ Trial of LP-300 in Never-Smoker, EGFR-Mutant NSCLC October 7, 2026 8:31 AM - BizWire Form 8-K Lantern Pharma Inc. For: Sep 25 October 1, 2026 4:01 PM - SEC Filing Form 8-K Lantern Pharma Inc. For: Sep 28 September 30, 2026 4:05 PM - SEC Filing Lantern Pharma closes $4M offering, warrants could add $4M more September 30, 2026 4:01 PM - StreetInsider Lantern Pharma Inc. Announces Closing of up to $8 Million Registered Direct Offering September 30, 2026 4:01 PM - BizWire Form 424B5 Lantern Pharma Inc. September 30, 2026 9:30 AM - SEC Filing Lantern Pharma launches $4M registered direct offering September 29, 2026 8:00 AM - StreetInsider Lantern Pharma Inc. Announces up to $8 Million Registered Direct Offering September 29, 2026 8:00 AM - BizWire New to The Street Show 773 Premieres Tonight on Bloomberg Television, Featuring Glint, Sagtec Global, BioVie and SafeSpace Global September 26, 2026 10:29 AM - StreetInsider Form 8-K Lantern Pharma Inc. For: Sep 23 September 24, 2026 6:01 AM - SEC Filing Form 8-K Lantern Pharma Inc. For: Sep 23 September 23, 2026 7:45 AM - SEC Filing Open-Medicine AI: Lantern Pharma to Present the Agentic AI Drug Development Market, User Needs, Development Roadmap, Platform Economics, and Benchmarks, Today at 12:30 PM ET September 23, 2026 7:45 AM - BizWire Lantern Pharma receives USPTO patent allowance for LP-284 through 2042 September 22, 2026 7:45 AM - StreetInsider Lantern Pharma Secures USPTO Notice of Allowance for LP‑284 Treatment Patent in Aggressive B‑Cell Lymphomas September 22, 2026 7:45 AM - BizWire New to The Street Broadcasts Tonight at 6:30 PM ET Across the United States, Latin America and MENA, Featuring BioVie, Acurx Pharmaceuticals, Lantern Pharma and SafeSpace Global September 19, 2026 11:46 AM - StreetInsider Lantern Pharma to Present Open-Medicine AI — a Multi-Agentic Platform for End-to-End Therapeutic Development — Business Model, Roadmap, and Value Proposition on September 23 September 17, 2026 8:20 AM - BizWire New to The Street Show 771 Airs Today on Bloomberg, Featuring Bill Mobley, Panna Sharma, Phillip Toppino and Dr. Kelley Gurley September 12, 2026 10:37 AM - StreetInsider New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST) September 5, 2026 10:51 AM - StreetInsider New to The Street Broadcasting Today at 6:30 PM EST on Bloomberg Television Across the U.S., Latin America and MENA-Featuring FreeCast (NASDAQ: CAST), Metaterra Holdings (MTHI) and SafeSpace Global (S August 29, 2026 9:23 AM - StreetInsider Form 8-K Lantern Pharma Inc. For: Aug 14 August 14, 2026 7:36 AM - SEC Filing Form 10-Q Lantern Pharma Inc. For: Jun 30 August 14, 2026 7:31 AM - SEC Filing Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business Update August 14, 2026 7:30 AM - BizWire New to The Street Show 766 Broadcasts Tonight at 6:30 PM ET on Bloomberg Television, Featuring BioVie's Bezisterim Parkinson's Disease Clinical Results August 8, 2026 12:01 PM - StreetInsider Lantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ET August 7, 2026 8:00 AM - BizWire Form SCHEDULE 13G Lantern Pharma Inc. Filed by: Empery Asset Management, LP August 4, 2026 10:04 AM - SEC Filing Form 8-K Lantern Pharma Inc. For: Aug 03 August 3, 2026 5:25 PM - SEC Filing Lantern Pharma spins out AI platform into separate company August 3, 2026 7:31 AM - StreetInsider Lantern Pharma (Nasdaq: LTRN) Establishes Open-Medicine AI as a Separate Company to Commercialize and Expand Its Multi-Agent AI Co-Scientist Platform for the Transformation of Medicine August 3, 2026 7:30 AM - BizWire Lantern Pharma gets EMA clearance for bladder cancer drug trial July 28, 2026 7:45 AM - StreetInsider Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer July 28, 2026 7:45 AM - BizWire New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings July 25, 2026 1:10 PM - StreetInsider Form SCHEDULE 13G/A Lantern Pharma Inc. Filed by: SATTERFIELD THOMAS A JR July 23, 2026 1:47 PM - SEC Filing Lantern Pharma receives USPTO patent allowance for LP-184 biomarker July 23, 2026 8:01 AM - StreetInsider Lantern Pharma Receives USPTO Notice of Allowance for Patent Covering Biomarker-Guided Treatment with LP-184 (Zirdafulven) in Multiple Solid Tumor Cancers July 23, 2026 8:01 AM - BizWire Full Article List